StockNews.com Upgrades Select Medical (NYSE:SEM) to “Buy”

StockNews.com upgraded shares of Select Medical (NYSE:SEMFree Report) from a hold rating to a buy rating in a research note published on Monday morning.

Several other equities research analysts have also issued reports on the stock. Royal Bank of Canada increased their target price on shares of Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a report on Monday, November 4th. Benchmark downgraded Select Medical from a “buy” rating to a “hold” rating in a research report on Monday, November 25th. Finally, UBS Group cut their price objective on shares of Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a research report on Friday, January 3rd. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $39.50.

Read Our Latest Report on SEM

Select Medical Stock Performance

Shares of SEM stock opened at $20.36 on Monday. The company’s 50-day moving average is $21.64 and its 200 day moving average is $30.47. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13. Select Medical has a one year low of $18.02 and a one year high of $40.98. The company has a market capitalization of $2.64 billion, a price-to-earnings ratio of 9.51, a price-to-earnings-growth ratio of 0.65 and a beta of 1.45.

Select Medical (NYSE:SEMGet Free Report) last released its quarterly earnings data on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.07. The firm had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.74 billion. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The firm’s quarterly revenue was up 5.7% on a year-over-year basis. During the same period in the previous year, the company earned $0.46 earnings per share. Sell-side analysts expect that Select Medical will post 1.97 EPS for the current fiscal year.

Select Medical Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, November 26th. Shareholders of record on Wednesday, November 13th were issued a dividend of $0.125 per share. The ex-dividend date of this dividend was Wednesday, November 13th. This represents a $0.50 annualized dividend and a yield of 2.46%. Select Medical’s payout ratio is currently 23.36%.

Insider Activity at Select Medical

In other Select Medical news, VP Robert G. Breighner, Jr. sold 4,989 shares of the firm’s stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total value of $99,530.55. Following the completion of the sale, the vice president now directly owns 30,356 shares in the company, valued at $605,602.20. This trade represents a 14.12 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Marilyn B. Tavenner sold 32,000 shares of the stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total value of $674,880.00. Following the sale, the director now owns 22,000 shares of the company’s stock, valued at approximately $463,980. This represents a 59.26 % decrease in their position. The disclosure for this sale can be found here. 19.14% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Select Medical

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Point72 Asset Management L.P. increased its position in shares of Select Medical by 144.2% in the 3rd quarter. Point72 Asset Management L.P. now owns 2,059,791 shares of the health services provider’s stock valued at $71,825,000 after acquiring an additional 1,216,263 shares during the period. Millennium Management LLC boosted its position in Select Medical by 183.9% during the second quarter. Millennium Management LLC now owns 679,522 shares of the health services provider’s stock worth $23,824,000 after purchasing an additional 440,140 shares in the last quarter. Loomis Sayles & Co. L P acquired a new stake in Select Medical in the 3rd quarter valued at $9,710,000. LMR Partners LLP acquired a new stake in shares of Select Medical in the third quarter valued at about $6,139,000. Finally, Bank of Montreal Can increased its stake in Select Medical by 798.2% during the 2nd quarter. Bank of Montreal Can now owns 180,566 shares of the health services provider’s stock worth $6,351,000 after buying an additional 160,462 shares in the last quarter. 89.48% of the stock is currently owned by hedge funds and other institutional investors.

About Select Medical

(Get Free Report)

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

Read More

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.